Cargando…
Immune Checkpoint Blockade in HER2-Positive Breast Cancer: What Role in Early Disease Setting?
SIMPLE SUMMARY: This work aims to discuss how an anti- or pro-tumor immune response could be manipulated through immune checkpoint blockade in patients with early stage HER2-positive breast cancer. By summarizing previously published evidence in the field, authors present their personal view on how...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036848/ https://www.ncbi.nlm.nih.gov/pubmed/33916115 http://dx.doi.org/10.3390/cancers13071655 |